Loading clinical trials...
Loading clinical trials...
Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70.
Conditions
Interventions
Alcon Investigational Agent
Locations
1
United States
Clinical Trial Sites
Fort Worth, Texas, United States
Start Date
February 1, 2001
Primary Completion Date
November 1, 2003
Completion Date
November 1, 2003
Last Updated
August 5, 2008
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
NCT06689696
Lead Sponsor
Alcon Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions